Exploiting the timsTOF and MALDI-2 Platforms to Assess Pharmacodynamics and Pharmacokinetics in Preclinical Models
Technology Networks: Exploiting the timsTOF and MALDI-2 Platforms to Assess Pharmacodynamics and Pharmacokinetics in Preclinical Models
An integrated evaluation of the pharmacodynamic and pharmacokinetic properties of a drug is essential for successful translation to the clinic. However, cost-effective methods to measure these parameters at the systems level in pre-clinical models are lacking.
Here, we introduce a timsTOF and MALDI-2 workflow to evaluate therapeutic activity. The platform combines ion mobility, mass spectrometry-based imaging, absolute drug quantitation across different biological matrices, in vivo isotope tracing, and global metabolome analysis in the adult zebrafish.
Attend this webinar to:
- Learn about innovative metabolomics workflows
- Discover how the Bruker timsTOF Pro and fleX systems can be used in metabolomics workflows
- Learn how the MALDI-2 post-ionization laser can see never before observed compounds
Presenter: Gary Patti, PhD (Professor, Department of Chemistry, Washington University in St. Louis)